GLAXOSMITHKLINE PHARMACEUTICALS
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹1,385 Cr | ₹1,255 Cr | ₹960 Cr | ₹841 Cr | ₹2,476 Cr |
| Adjustment | ₹-65 Cr | ₹-68 Cr | ₹-45 Cr | ₹-40 Cr | ₹-1,636 Cr |
| Changes In working Capital | ₹-98 Cr | ₹185 Cr | ₹61 Cr | ₹-46 Cr | ₹120 Cr |
| Cash Flow after changes in Working Capital | ₹1,222 Cr | ₹1,372 Cr | ₹976 Cr | ₹756 Cr | ₹959 Cr |
| Cash Flow from Operating Activities | ₹903 Cr | ₹1,290 Cr | ₹582 Cr | ₹484 Cr | ₹811 Cr |
| Cash Flow from Investing Activities | ₹397 Cr | ₹-46 Cr | ₹8.71 Cr | ₹808 Cr | ₹-406 Cr |
| Cash Flow from Financing Activities | ₹-737 Cr | ₹-769 Cr | ₹-561 Cr | ₹-1,543 Cr | ₹-524 Cr |
| Net Cash Inflow / Outflow | ₹563 Cr | ₹475 Cr | ₹29 Cr | ₹-251 Cr | ₹-119 Cr |
| Opening Cash & Cash Equivalents | ₹539 Cr | ₹64 Cr | ₹35 Cr | ₹286 Cr | ₹405 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
| Effect of Foreign Exchange Fluctuations | - | - | - | - | - |
| Closing Cash & Cash Equivalent | ₹1,102 Cr | ₹539 Cr | ₹64 Cr | ₹35 Cr | ₹286 Cr |
Compare Cashflow Statement of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹50,090.7 Cr | -1.3% | 14% | 7.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,826.0 Cr | -1.6% | -2.5% | 21.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,019.0 Cr | 1.5% | 12.8% | 48.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,875.0 Cr | -0.9% | -0.8% | 35.3% | Stock Analytics | |
| CIPLA | ₹112,773.0 Cr | -1.6% | -5.2% | -11.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,570.9 Cr | -2.2% | -2.3% | -8.2% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | -1.3% |
14% |
7.6% |
| SENSEX | -1.1% |
-3.6% |
-5.3% |
You may also like the below Video Courses